Functionalized Prussian Blue Nanozyme as Dual-Responsive Drug Therapeutic Nanoplatform Against Maxillofacial Infection via Macrophage Polarization
Junlong Da,Ying Li,Kai Zhang,Junyu Ren,Jianqun Wang,Xinpeng Liu,Xiaoyao Liu,Jiahui Zhang,Lixue Liu,Wenxuan Zhang,Shujian Zhang,Yuyao Guo,Bin Zhang,Han Jin
DOI: https://doi.org/10.2147/IJN.S385899
IF: 7.033
2022-12-01
International Journal of Nanomedicine
Abstract:Junlong Da, 1 Ying Li, 1 Kai Zhang, 1 Junyu Ren, 1 Jianqun Wang, 1 Xinpeng Liu, 1 Xiaoyao Liu, 2 Jiahui Zhang, 1 Lixue Liu, 1 Wenxuan Zhang, 1 Shujian Zhang, 1 Yuyao Guo, 1 Bin Zhang, 1, 3 Han Jin 1 1 Heilongjiang Provincial Key Laboratory of Hard Tissue Development and Regeneration, the Second Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China; 2 Department of Orthodontics, the First Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China; 3 Heilongjiang Academy of Medical Sciences, Harbin, People's Republic of China Correspondence: Han Jin; Bin Zhang, Heilongjiang Provincial Key Laboratory of Hard Tissue Development and Regeneration, the Second Affiliated Hospital of Harbin Medical University, Harbin, 150001, People's Republic of China, Tel/Fax +86 0451-86297231, Email ; Purpose: Maxillofacial infection is a common disease in stomatology and is difficult to treat owing to its high potential to spread to vital anatomical structures. Excessive levels of reactive oxygen species (ROS) in infected tissues lead to cellular damage and impede tissue regeneration. However, uncontrollable strategies to remove ROS have limited therapeutic efficacy. Nanoparticle systems for scavenging ROS and remodeling the inflammatory microenvironment offer much promise in the treatment of maxillofacial inflammation. Methods: Here, a novel microenvironment-stimuli-responsive drug delivery nanoplatform (@PDA) based on a polydopamine (PDA)-functionalized hollow mesoporous Prussian blue (HMPB) nanozyme was developed for the delivery of curcumin (Cur) in the treatment of maxillofacial infection. Low pH and excess ROS in the inflammatory microenvironment cause degradation of the outer PDA layer of the nanocomplex, exposing the HMPB nanozyme and loaded Cur, which synergistically act as a ROS scavenger and anti-inflammatory agent, respectively, and induce macrophage polarization from the pro-inflammatory M1 to the anti-inflammatory M2 phenotype. Results: Experiments in vitro provided strong evidence for the application of novel nanocomplexes in scavenging multiple ROS and inhibiting lipopolysaccharide-induced inflammation. In addition, in vivo results obtained using a mouse maxillofacial infection model demonstrated that @PDA had excellent biocompatibility, significantly attenuated the inflammatory response in periodontal tissue, and improved the repair of damaged tissue. Conclusion: Our results indicate that @PDA nanocomposites have great potential for ROS regulation as well as having anti-inflammatory effects, providing new insights for the development of dual-response maxillofacial infection treatments. Keywords: maxillofacial infection, Prussian blue, nanozyme, polydopamine, reactive oxygen species, macrophage polarization Oral and maxillofacial infections mainly have odontogenic causes, that is, they originate from the tooth or its supporting tissue. Owing to its particular anatomical characteristics, the oral and maxillofacial region is highly susceptible to the spread of infection; thus, an infection that is not treated promptly and effectively may lead to cellulitis and osteomyelitis, and even develop into a life-threatening event in severe cases. 1–3 Currently, antibiotic-assisted anti-inflammatory therapy is frequently used in clinical practice. Although admirable results have been achieved, there is still little escape from the problem of resistance to widely used antibiotics. 4,5 Therefore, new therapies with anti-inflammatory and pro-repair capabilities are necessary for the development of a rational strategy for the treatment of oral infections. During the pathological process of maxillofacial infection, tissue destruction occurs when the balance between pathogenic bacteria and the immune response is destabilized. Briefly, the invading pathogen and its harmful metabolites trigger an innate immune response, in which immune cells (mainly macrophages and neutrophils) are recruited and activated in the affected regions. Pro-inflammatory cytokines and reactive oxygen species (ROS) such as hydrogen peroxide (H 2 O 2 ), superoxide (O 2 • − ), hydroxyl radicals (•OH), and singlet oxygen ( 1 O 2 ) are released. 6–8 The production of ROS by immune cells disrupts the balance of oxidative and antioxidant defense systems (eg, catalase (CAT), superoxide dismutase (SOD), and glutathione peroxidase), leading to oxidative stress, which is considered to be an integral part of the pathogenesis of inflammation. 9 Excess ROS dir -Abstract Truncated-